3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Completed
43
Terminated
6
Unknown
5
Withdrawn
3
Recruiting
2
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
15
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other
2
Head & Neck
2
Conditions
Carcinoma, Non-Small-Cell Lung
429
Breast Neoplasms
298
Neoplasms
296
Colorectal Neoplasms
242
Neoplasm Metastasis
197
Ovarian Neoplasms
171
Lung Neoplasms
150
Recurrence
147
Prostatic Neoplasms
146
Pancreatic Neoplasms
142
Multiple Myeloma
136
Stomach Neoplasms
129
Squamous Cell Carcinoma of Head and Neck
128
Melanoma
123
Leukemia, Myeloid, Acute
115
Endometrial Neoplasms
115
Advanced Solid Tumors
113
Advanced Solid Tumor
108
Carcinoma, Hepatocellular
102
Triple Negative Breast Neoplasms
101
Small Cell Lung Carcinoma
88
Uterine Cervical Neoplasms
86
Lymphoma, Non-Hodgkin
83
Carcinoma, Renal Cell
72
Lymphoma, Follicular
71
Lymphoma
67
Leukemia, Lymphocytic, Chronic, B-Cell
65
Solid Tumor
64
Lymphoma, Large B-Cell, Diffuse
64
Hematologic Neoplasms
62
Interventions
Xylitol
1
Radiotherapy, Intensity-Modulated
1
RRx-001
1
Injections
1
Cisplatin
1
Betaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
INDUSTRY
×
Stomatitis
×
Clear all
NCT05635929
2026-04-15
STOPOMP
Mucosa Innovations, S.L.
Phase NA
Recruiting
63 enrolled
NCT05966194
2024-11-15
KEVLARx
EpicentRx, Inc.
Phase 2
Recruiting
216 enrolled